Abstract
Background: Evidence suggests that the dimer configuration of methylenetetrahydrofolate reductase (MTHFR) enzyme might be destabilized by polymorphisms in monomers at the positions C677T and A1298C. It has been observed that these polymorphisms may lead to stable (CCAA, CCAC, CCCC) and unstable (CTAA, CTAC, TTAA) enzyme dimer configurations. Objective: The aim of this study was to evaluate the association of the MTHFR enzyme dimer configuration and folate dietary intake with the stage of meiotic nondisjunction in mothers of children with maternally derived trisomy 21. Methods: A total of 119 mothers of children with maternally derived free trisomy 21 were included in the study. The mean maternal age at the time of the birth of the child with trisomy 21 was 32.3 ± 6.4 (range 16–43) years. All mothers were Caucasian. Parental origin of trisomy 21 and meiotic stage of nondisjunction was determined using short tandem repeat markers spanning from the centromere to the telomere of chromosome 21q. The MTHFR C677T and A1298C polymorphism was evaluated by PCR-RFLP. Results: Increased frequency of the MTHFR genotype combinations CTAA, CTAC, and TTAA was found in the group of mothers with meiosis I (MI) nondisjunction (p = 0.007). No differences were found between study participants regarding dietary and lifestyles habits. Conclusion: The risk for MI nondisjunction of chromosome 21 was 4.6-fold higher in cases who had CTAA, CTAC, and TTAA MTHFR genotype combinations and who did not used folic acid supplements in the preconception period.
References
1.
Yamada
K
, Chen
Z
, Rozen
R
, Matthews
RG
. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase
. Proc Natl Acad Sci USA
. 2001
Dec
;98
(26
):14853
–8
.
[PubMed]
0027-84242.
Guenther
BD
, Sheppard
CA
, Tran
P
, Rozen
R
, Matthews
RG
, Ludwig
ML
. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia
. Nat Struct Biol
. 1999
Apr
;6
(4
):359
–65
.
[PubMed]
1072-83683.
Ulvik
A
, Ueland
PM
, Fredriksen
A
, Meyer
K
, Vollset
SE
, Hoff
G
, et al Functional inference of the methylenetetrahydrofolate reductase 677C [{GT}] T and 1298A [{GT}] C polymorphisms from a large-scale epidemiological study
. Hum Genet
. 2007
Mar
;121
(1
):57
–64
.
[PubMed]
0340-67174.
Costa-Lima
MA
, Amorim
MR
, Orioli
IM
. Association of methylenetetrahydrofolate reductase gene 677C [{GT}] T polymorphism and Down syndrome
. Mol Biol Rep
. 2013
Mar
;40
(3
):2115
–25
.
[PubMed]
0301-48515.
Wu
X
, Wang
X
, Chan
Y
, Jia
S
, Luo
Y
, Tang
W
. Folate metabolism gene polymorphisms MTHFR C677T and A1298C and risk for Down syndrome offspring: a meta-analysis
. Eur J Obstet Gynecol Reprod Biol
. 2013
Apr
;167
(2
):154
–9
.
[PubMed]
0301-21156.
Yang
M
, Gong
T
, Lin
X
, Qi
L
, Guo
Y
, Cao
Z
, et al Maternal gene polymorphisms involved in folate metabolism and the risk of having a Down syndrome offspring: a meta-analysis
. Mutagenesis
. 2013
Nov
;28
(6
):661
–71
.
[PubMed]
0267-83577.
Rai
V
, Yadav
U
, Kumar
P
, Yadav
SK
, Mishra
OP
. Maternal methylenetetrahydrofolate reductase C677T polymorphism and down syndrome risk: a meta-analysis from 34 studies
. PLoS One
. 2014
Sep
;9
(9
):e108552
.
[PubMed]
1932-62038.
Victorino
DB
, Godoy
MF
, Goloni-Bertollo
EM
, Pavarino
EC
. Meta-analysis of Methylenetetrahydrofolate reductase maternal gene in Down syndrome: increased susceptibility in women carriers of the MTHFR 677T allele
. Mol Biol Rep
. 2014
Aug
;41
(8
):5491
–504
.
[PubMed]
0301-48519.
Coppedè
F
. The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects
. Front Genet
. 2015
Jun
;6
:223
.
[PubMed]
1664-802110.
Freeman
SB
, Allen
EG
, Oxford-Wright
CL
, Tinker
SW
, Druschel
C
, Hobbs
CA
, et al The National Down Syndrome Project: design and implementation
. Public Health Rep
. 2007
Jan-Feb
;122
(1
):62
–72
.
[PubMed]
0033-354911.
Colić Barić
I
, Satalić
Z
, Pedisić
Z
, Zizić
V
, Linarić
I
. Validation of the folate food frequency questionnaire in vegetarians
. Int J Food Sci Nutr
. 2009
;60
(sup5
Suppl 5
):88
–95
.
[PubMed]
0963-748612.
Vraneković
J
, Babić Bozović
I
, Starcević Cizmarević
N
, Buretić-Tomljanović
A
, Ristić
S
, Petrović
O
, et al Functional inference of methylenetetrahydrofolate reductase gene polymorphisms on enzyme stability as a potential risk factor for Down syndrome in Croatia
. Dis Markers
. 2010
;28
(5
):293
–8
.
[PubMed]
0278-024013.
Coppedè
F
, Marini
G
, Bargagna
S
, Stuppia
L
, Minichilli
F
, Fontana
I
, et al Folate gene polymorphisms and the risk of Down syndrome pregnancies in young Italian women
. Am J Med Genet A
. 2006
May
;140
(10
):1083
–91
.
[PubMed]
1552-482514.
Martínez-Frías
ML
. The biochemical structure and function of methylenetetrahydrofolate reductase provide the rationale to interpret the epidemiological results on the risk for infants with Down syndrome
. Am J Med Genet A
. 2008
Jun
;146A
(11
):1477
–82
.
[PubMed]
1552-482515.
de Massy
B
. Initiation of meiotic recombination: how and where? Conservation and specificities among eukaryotes
. Annu Rev Genet
. 2013
;47
(1
):563
–99
.
[PubMed]
0066-419716.
James
SJ
, Pogribna
M
, Pogribny
IP
, Melnyk
S
, Hine
RJ
, Gibson
JB
, et al Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome
. Am J Clin Nutr
. 1999
Oct
;70
(4
):495
–501
.
[PubMed]
0002-916517.
Božović
IB
, Stanković
A
, Živković
M
, Vraneković
J
, Kapović
M
, Brajenović-Milić
B
. Altered LINE-1 methylation in mothers of children with down syndrome
. PLoS One
. 2015
May
;10
(5
):e0127423
.
[PubMed]
1932-620318.
Vraneković
J
, Božović
IB
, Grubić
Z
, Wagner
J
, Pavlinić
D
, Dahoun
S
, et al Down syndrome: parental origin, recombination, and maternal age
. Genet Test Mol Biomarkers
. 2012
Jan
;16
(1
):70
–3
.
[PubMed]
1945-026519.
Oliver
TR
, Tinker
SW
, Allen
EG
, Hollis
N
, Locke
AE
, Bean
LJ
, et al Altered patterns of multiple recombinant events are associated with nondisjunction of chromosome 21
. Hum Genet
. 2012
Jul
;131
(7
):1039
–46
.
[PubMed]
0340-671720.
Middlebrooks CD, Mukhopadhyay N, Tinker SW, Allen EG, Bean LJH, Begum F, et al. Evidence for dysregulation of genome-wide recombination in oocytes with nondisjoined chromosomes 21. Hum Mol Genet. 2014 Jan;23(2):408–17.
21.
Termolino
P
, Cremona
G
, Consiglio
MF
, et al Insights into epigenetic landscape of recombination-free regions.
Chromosoma. 2016.125(2):301-308. 22.
Sukla
KK
, Jaiswal
SK
, Rai
AK
, Mishra
OP
, Gupta
V
, Kumar
A
, et al Role of folate-homocysteine pathway gene polymorphisms and nutritional cofactors in Down syndrome: A triad study
. Hum Reprod
. 2015
Aug
;30
(8
):1982
–93
.
[PubMed]
0268-116123.
Sullivan
M
, Murray
T
, Assefa
H
. Women with Methylenetetrahydrofolate Reductase Gene Polymorphism and the Need for Proper Periconceptional Folate Supplementation
. J Pharm Pharmacol
. 2015
;3
:204
–22
.0022-357324.
Hollis
ND
, Allen
EG
, Oliver
TR
, et al Preconception folic acid supplementation and risk for chromosome 21 nondisjunction: A report from the National Down Syndrome Project.
Am J Med Genet Part A. DOI:.25.
Kaur
A
, Kaur
A
. Maternal MTHFR polymorphism (677 C-T) and risk of Down’s syndrome child: meta-analysis
. J Genet
. 2016
Sep
;95
(3
):505
–13
.
[PubMed]
0022-133326.
Kedar
R
, Chandel
D
. MTHFR gene polymorphism and associated nutritional deficiency in the etiology and pathogenesis of Down syndrome
. Egypt J Med Hum Genet
. 2019
;20
(1
):12
. 1110-863027.
Coppedè
F
, Migheli
F
, Bargagna
S
, Siciliano
G
, Antonucci
I
, Stuppia
L
, et al Association of maternal polymorphisms in folate metabolizing genes with chromosome damage and risk of Down syndrome offspring
. Neurosci Lett
. 2009
Jan
;449
(1
):15
–9
.
[PubMed]
0304-3940© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
